BMW raises stake in China car venture with US$4.1 billion deal

The German firm will be the first foreign carmaker to participate in China’s recent revised policy allowing foreign firms to hold a majority share in local partnerships.

bg_bmw_1353427

BMW AG is raising its stake in Brilliance China Automotive Holding from the existing 50 percent to 75 percent, through a top up of US$4.1 billion (€3.6 billion), the carmaker said in a statement on Thursday.

The German firm will be the first foreign carmaker to participate in China’s recent revised policy allowing foreign firms to hold a majority share in local partnerships.

The deal which is expected to complete in 2022 when rules limiting foreign ownership for all auto ventures are lifted, will allow BMW increased manufacturing capacity and grow its car production – including electric cars - prowess in China. The agreement will hence give the group a larger share of the earnings generated from the market.

For decades, China had a 50:50 joint-venture rule which limited global companies from growing their stake in the Chinese market. The policy tweaks which China announced in April, shows the Chinese government opening up its economy to foreign ownership.

As a major exporter of vehicles from the United States to China, BMW had earlier warned that trade tensions between the two nations could put a drag on the carmaker’s profits.

Brilliance China, which has a market capitalisation of about US$7 billion, has seen its shares battered by the ongoing speculation of the increased stake from BMW. The decline has been led by investor concerns as the firm will receive a smaller portion of earnings from the joint venture following the deal arrangement. The stock has slid 49 percent this year.

BMW’s shares have shrunk 15 percent year-to-date. The counter closed on Wednesday 1.36 percent or €1.04 lower, at €75.35.

Under the joint venture with Brilliance China, BMW is slated to build its first pure electric vehicle in China by 2020. The model will be sold in China and exported to other markets.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IG Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.

Find articles by writer